Therapeutic drug monitoring in highly active antiretroviral therapy
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic drug monitoring in highly active antiretroviral therapy
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 9, Issue 5, Pages 743-758
Publisher
Informa Healthcare
Online
2010-03-30
DOI
10.1517/14740331003767395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin
- (2009) Matthijs van Luin et al. AIDS
- A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients
- (2009) Lisa M Demeter et al. AIDS
- Antiretroviral Therapy
- (2009) Sarah M McCabe et al. CLINICAL PHARMACOKINETICS
- Intra-Individual Variability in Efavirenz Plasma Concentrations Supports Therapeutic Drug Monitoring Based on Quarterly Sampling in the First Year of Therapy
- (2009) Sofia A Pereira et al. THERAPEUTIC DRUG MONITORING
- Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring
- (2008) Sonia Rodríguez-Nóvoa et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Concomitant Use of Nonnucleoside Analogue Reverse Transcriptase Inhibitors and Rifampicin in TB/HIV Type 1-Coinfected Patients
- (2008) Leena Sathia et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women
- (2008) Matthieu Roustit et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV‐Infected Subjects: A Randomized, Controlled Study
- (2008) G. A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults
- (2008) A Avihingsanon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- “White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients
- (2008) Thomas J. Podsadecki et al. HIV CLINICAL TRIALS
- Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children
- (2008) U. Wintergerst et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration in human plasma by MALDI-TOF/TOF
- (2008) Stefania Notari et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Single-Measurement Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Lamivudine, Efavirenz, Nevirapine, Lopinavir and Nelfinavir
- (2008) Josef Donnerer et al. PHARMACOLOGY
- Thérapeutiques antirétrovirales : principes du traitement de l’infection par le VIH
- (2008) Odile Launay PRESSE MEDICALE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now